REVIEW ARTICLE published: 03 April 2014 doi: 10.3389/fphys.2014.00122 The future of vitamin D analogs Carlien Leyssens , Lieve Verlinden and Annemieke Verstuyf* Clinical…
A FluoPol-ABPP PAD2 High-Throughput Screen Identifies the First Calcium Site Inhibitor Targeting the PADs Daniel M. Lewallen,† Kevin L. Bicker,† Franck Madoux,§ Peter…
Opportunity Overview SphingoGene, Inc. Delaware C-Corporation Small Molecule Platform for Improving Radiation Treatment of Prostate and other Cancers 1 1 Background on SphingoGene…